je.st
news
Tag: receives
FedEx Co. (FDX) Receives BBB+ Credit Rating
2015-12-08 09:53:04| Air Courier - Topix.net
FedEx Co. has been given a "BBB+" credit rating by analysts at Morningstar . The firm's "BBB+" rating suggests that the company is a moderate default risk.
Tags: rating
credit
receives
bbb
Pennine Receives Notification Of Successful Bid For Block Velca Territory In Albania
2015-12-08 01:37:03| oilandgasonline Home Page
Pennine Petroleum Corporation is pleased to announce that it has received notification from licensee Albpetrol Sh.A., that Pennine was confirmed on Dec. 2, 2015 by the Republic of Albania’s Ministry of Energy and Industry as the successful bidder for Block Velca.
Tags: successful
block
bid
notification
Zacks: AudioCodes Ltd. (NASDAQ:AUDC) Receives Consensus...
2015-12-07 20:06:31| Semiconductors - Topix.net
Shares of AudioCodes Ltd. have received a consensus broker rating score of 1.00 from the two analysts that cover the company, Zacks Investment Research reports. Two research analysts have rated the stock with a strong buy recommendation.
Tags: receives
consensus
zacks
audiocodes
Zacks: Kyocera Corp (NYSE:KYO) Receives Average Rating of "Sell" from Brokerages
2015-12-07 20:06:29| Semiconductors - Topix.net
Kyocera Corp has received a consensus broker rating score of 3.50 from the two analysts that cover the company, Zacks Investment Research reports. One research analyst has rated the stock with a sell recommendation and one has issued a hold recommendation on the company.
Tags: rating
sell
average
corp
Merck Announces Samsung Bioepis Receives Approval of RENFLEXIS (Infliximab), a Biosimilar of Remicade, in Korea
2015-12-07 14:00:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. Samsung Bioepis Second Immunology Biosimilar Approved, to be Commercialized Under Partnership with Merck KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that Samsung Bioepis Co., Ltd. has received approval of RENFLEXIS (infliximab), a biosimilar of the immunology medicine Remicade, by the Ministry of Food and Drug Safety (MFDS) in Korea. Merck will commercialize Samsung Bioepis RENFLEXIS in Korea as part of Mercks commercialization partnership with Samsung Bioepis to offer high-quality biosimilar alternatives to existing biologic medicines. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orRobert Consalvo, 908-236-1127orInvestors:Teri Loxam, 908-740-1986orAmy Klug, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: korea
samsung
approval
receives
Sites : [258] [259] [260] [261] [262] [263] [264] [265] [266] [267] [268] [269] [270] [271] [272] [273] [274] [275] [276] [277] next »